We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 FTSE 100 dividend stocks I’d buy today

With such a large number of companies cancelling or cutting dividends, income has been hard to come by. These dividend stocks should help fill the hole.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a pretty dismal year for income investors. A total of 445 companies listed on the London Stock Exchange have either cancelled, cut or suspended dividend payments. This has included previous big dividend-payers such as BT Group and Royal Dutch Shell. Nonetheless, some FTSE 100 companies have remained committed to payments, and these two dividend stocks are my top picks.

A pharmaceuticals giant

GlaxoSmithKline (LSE: GSK) is one of the leading healthcare companies in the world. The group operates in three different business segments, including pharmaceuticals, vaccines and consumer healthcare. And while this is seen as a fairly defensive sector, especially during a pandemic, the giant group hasn’t been immune to the impacts of coronavirus. For example, turnover in the vaccines sector fell by 29% in the second quarter as regular vaccination programmes were delayed. And adjusted operating profits were 19% lower than the previous year. This has seen its share price fall by 20% this year, leaving the stock looking very cheap indeed.

XXX

But it’s the firm’s status as a dividend stock that grabs my interest. While there has been limited dividend growth over the years, the company has consistently made dividend payments of 80p a year. At its currently depressed price, this equates to a very strong yield of 5.6%. With dividend cover of around 1.6, the payout is also well-covered by earnings, and I can’t see a cut coming any time soon. Consequently, I’d buy Glaxo shares at their current valuation.

A dividend stock yielding over 8%

Often a very high dividend yield can indicate limited growth in a company. A dividend cut may also be very likely at some point in the near future. Even so, in the case of Legal & General (LSE: LGEN), I think neither of these apply.

For example, the firm has seen significant growth in the past few years, with 2019 earnings rising 12% from the year before. The first-half trading update was also positive, and operating profits totalled £946m. This was only a 6% decrease compared to the same period in 2019, showing a strong performance in a difficult economic environment. I believe that the insurer should be able to continue growing profits over the next few years, thanks to its status as the UK’s leader in bulk annuities, life insurance and other retirement products. An ageing population should help to drive this growth.

Strong profits also allowed the group to announce an interim dividend of 4.93p. This corresponds to a total year payout of 17.57p, or a very high yield of 8.6%. The fact that the dividend was higher than the previous year further demonstrates LGEN’s standing as an excellent dividend stock. I reckon investors can expect further increases in the forthcoming years, and as such, I’d happily buy this stock today.

Stuart Blair owns shares in Legal & General and Royal Dutch Shell. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »